GlucoTrack Inc

GCTK: Accountant’s Review Report

GlucoTrack Inc (GCTK) just filed. GCTK: Accountant’s Review Report (8-K 2026-08-28). Why it matters: expects to continue to incur substantial losses in the future. As of June 30, 2026, the Company had cash and cash equivalents

Those exhibit numbers sit next to the income-statement cache: Net income was -$4.2M. GCTK currently screens at market cap $4.1M and trailing P/E 0.1. The GCTK filings page is the source view; the stock page is the research view.

EDGAR remains the official archive. Lician caches 8-K exhibits so you can read what GlucoTrack Inc said without waiting on a live EDGAR scrape. Item 2.02 is the earnings exhibit — this page prefers EX-99.1 revenue, growth, EPS, and guidance over a form-type label. Form 4 insider prints stay on the same ticker timeline.

8-KEX-99.12.019.01

Accountant’s Review Report

GCTK: Accountant’s Review Report

Why it matters

  • expects to continue to incur substantial losses in the future. As of June 30, 2026, the Company had cash and cash equivalents
Source on EDGAR

0

10-K

0

10-Q

9

8-K

0

Form 4

Recent filings

8-K2.019.01

Accountant’s Review Report

GCTK: Accountant’s Review Report

EDGAR
8-K5.038.019.01

8-K exhibit

EDGAR
8-K7.019.01

8-K exhibit

EDGAR
8-K

8-K exhibit

EDGAR
8-K1.012.033.02

8-K exhibit

EDGAR
8-K7.019.01

8-K exhibit

EDGAR
8-K1.012.033.02

8-K exhibit

EDGAR
8-K1.012.033.02

8-K exhibit

EDGAR
8-K1.012.012.03

8-K exhibit

EDGAR

EDGAR is the official archive. Browse all GCTK filings.

Frequently asked questions

What did GCTK just say?

GCTK: Accountant’s Review Report

Where are GCTK SEC filings?

9 cached filings are on this page. EDGAR remains the official archive (CIK 0001506983).

What is an 8-K Item 2.02?

Item 2.02 is the earnings exhibit. Lician reads EX-99.1 for revenue, growth, EPS, and guidance — not a form-type label.